• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD73 促进动脉粥样硬化的年龄相关性堆积。

CD73 Promotes Age-Dependent Accretion of Atherosclerosis.

机构信息

From the Department of Internal Medicine, Division of Cardiovascular Medicine (N.R.S., D.B., K.M.M., A.M., I.M.R., D.R.G., D.J.P.), University of Michigan Medical Center, Ann Arbor.

Division of Pulmonary and Critical Care (A.L.M.), University of Michigan Medical Center, Ann Arbor.

出版信息

Arterioscler Thromb Vasc Biol. 2020 Jan;40(1):61-71. doi: 10.1161/ATVBAHA.119.313002. Epub 2019 Oct 17.

DOI:10.1161/ATVBAHA.119.313002
PMID:31619062
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7956240/
Abstract

OBJECTIVE

CD73 is an ectonucleotidase which catalyzes the conversion of AMP (adenosine monophosphate) to adenosine. Adenosine has been shown to be anti-inflammatory and vasorelaxant. The impact of ectonucleotidases on age-dependent atherosclerosis remains unclear. Our aim was to investigate the role of CD73 in age-dependent accumulation of atherosclerosis. Approach and results: Mice doubly deficient in CD73 and ApoE (apolipoprotein E; () were generated, and the extent of aortic atherosclerotic plaque was compared with controls at 12, 20, 32, and 52 weeks. By 12 weeks of age, mice exhibited a significant increase in plaque (1.4±0.5% of the total vessel surface versus 0.4±0.1% in controls, <0.005). By 20 weeks of age, this difference disappeared (2.9±0.4% versus 3.3±0.7%). A significant reversal in phenotype emerged at 32 weeks (9.8±1.2% versus 18.3±1.4%; <0.0001) and persisted at the 52 week timepoint (22.4±2.1% versus 37.0±2.1%; <0.0001). The inflammatory response to aging was found to be comparable between mice and controls. A reduction in lipolysis in CD73 competent mice was observed, even with similar plasma lipid levels ( versus at 12 weeks [16.2±0.7 versus 9.5±1.4 nmol glycerol/well], 32 weeks [24.1±1.5 versus 7.4±0.4 nmol/well], and 52 weeks [13.8±0.62 versus 12.7±2.0 nmol/well], <0.001).

CONCLUSIONS

At early time points, CD73 exerts a subtle antiatherosclerotic influence, but with age, the pattern reverses, and the presence of CD73 promoted suppression of lipid catabolism.

摘要

目的

CD73 是一种外核苷酸酶,可催化 AMP(单磷酸腺苷)转化为腺苷。已证明腺苷具有抗炎和血管舒张作用。外核苷酸酶对年龄相关性动脉粥样硬化的影响尚不清楚。我们的目的是研究 CD73 在年龄相关性动脉粥样硬化积累中的作用。

方法和结果

生成了 CD73 和载脂蛋白 E(ApoE;)双重缺陷的小鼠,并比较了 12、20、32 和 52 周时主动脉粥样硬化斑块的程度与 对照组。12 周龄时,与 对照组(0.4±0.1%)相比,小鼠的斑块显著增加(1.4±0.5%),<0.005。20 周龄时,这种差异消失(2.9±0.4%与 3.3±0.7%)。32 周时,表型出现显著逆转(9.8±1.2%与 18.3±1.4%,<0.0001),并持续至 52 周(22.4±2.1%与 37.0±2.1%,<0.0001)。发现衰老引起的炎症反应在 小鼠和 对照组之间相似。即使血浆脂质水平相似,也观察到 CD73 功能正常的小鼠脂肪分解减少(12 周时为 (16.2±0.7 与 9.5±1.4 nmol 甘油/孔),32 周时为 (24.1±1.5 与 7.4±0.4 nmol/孔),52 周时为 (13.8±0.62 与 12.7±2.0 nmol/孔),<0.001)。

结论

在早期阶段,CD73 发挥微妙的抗动脉粥样硬化作用,但随着年龄的增长,这种模式发生逆转,CD73 的存在促进了脂质分解代谢的抑制。

相似文献

1
CD73 Promotes Age-Dependent Accretion of Atherosclerosis.CD73 促进动脉粥样硬化的年龄相关性堆积。
Arterioscler Thromb Vasc Biol. 2020 Jan;40(1):61-71. doi: 10.1161/ATVBAHA.119.313002. Epub 2019 Oct 17.
2
Inactivation of CD73 promotes atherogenesis in apolipoprotein E-deficient mice.CD73 的失活促进载脂蛋白 E 缺陷小鼠的动脉粥样硬化形成。
Cardiovasc Res. 2011 Nov 1;92(2):338-47. doi: 10.1093/cvr/cvr218. Epub 2011 Sep 28.
3
Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.蛋白酶激活受体-2在载脂蛋白 E 缺陷型小鼠血管炎症和动脉粥样硬化中发挥关键作用。
Circulation. 2018 Oct 16;138(16):1706-1719. doi: 10.1161/CIRCULATIONAHA.118.033544.
4
Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.内皮细胞特异性缺失P2Y2受体可促进动脉粥样硬化易感载脂蛋白E基因敲除小鼠的斑块稳定性。
Arterioscler Thromb Vasc Biol. 2017 Jan;37(1):75-83. doi: 10.1161/ATVBAHA.116.308561. Epub 2016 Nov 17.
5
The volatile anesthetic isoflurane induces ecto-5'-nucleotidase (CD73) to protect against renal ischemia and reperfusion injury.挥发性麻醉剂异氟醚诱导外核苷酸酶 (CD73) 以防止肾缺血再灌注损伤。
Kidney Int. 2013 Jul;84(1):90-103. doi: 10.1038/ki.2013.43. Epub 2013 Feb 20.
6
Deletion of CD73 promotes dyslipidemia and intramyocellular lipid accumulation in muscle of mice.CD73 缺失促进了小鼠肌肉中的血脂异常和肌内脂质堆积。
Arch Physiol Biochem. 2013 May;119(2):39-51. doi: 10.3109/13813455.2012.755547. Epub 2013 Feb 11.
7
CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression.肿瘤细胞上的 CD73 抑制抗肿瘤 T 细胞反应:肿瘤诱导免疫抑制的新机制。
Cancer Res. 2010 Mar 15;70(6):2245-55. doi: 10.1158/0008-5472.CAN-09-3109. Epub 2010 Feb 23.
8
SAP deficiency mitigated atherosclerotic lesions in ApoE(-/-) mice.SAP缺乏减轻了ApoE(-/-)小鼠的动脉粥样硬化病变。
Atherosclerosis. 2016 Jan;244:179-87. doi: 10.1016/j.atherosclerosis.2015.11.009. Epub 2015 Nov 23.
9
Deficiency of endogenous acute phase serum amyloid A does not affect atherosclerotic lesions in apolipoprotein E-deficient mice.内源性急性期血清淀粉样蛋白 A 缺乏并不影响载脂蛋白 E 缺陷小鼠的动脉粥样硬化病变。
Arterioscler Thromb Vasc Biol. 2014 Feb;34(2):255-61. doi: 10.1161/ATVBAHA.113.302247. Epub 2013 Nov 21.
10
RNAi-mediated CD73 suppression induces apoptosis and cell-cycle arrest in human breast cancer cells.RNAi 介导的 CD73 抑制诱导人乳腺癌细胞凋亡和细胞周期停滞。
Cancer Sci. 2010 Dec;101(12):2561-9. doi: 10.1111/j.1349-7006.2010.01733.x. Epub 2010 Sep 28.

引用本文的文献

1
Prognostic value of lipid variability for recurrence and mortality in elderly patients with acute ischemic cerebrovascular disease.脂质变异性对老年急性缺血性脑血管病患者复发和死亡率的预后价值。
Am J Transl Res. 2025 Jun 15;17(6):4651-4662. doi: 10.62347/RFBV1794. eCollection 2025.
2
Increased primary breast tumor expression of CD73 is associated with development of bone metastases and is a potential biomarker for adjuvant bisphosphonate use.原发性乳腺肿瘤中CD73表达增加与骨转移的发生相关,并且是辅助使用双膦酸盐的潜在生物标志物。
Sci Rep. 2025 Mar 19;15(1):9449. doi: 10.1038/s41598-025-92841-9.
3
CD73: agent development potential and its application in diabetes and atherosclerosis.

本文引用的文献

1
Multifaceted Mechanisms of Vascular Calcification in Aging.衰老过程中心血管钙化的多因素机制。
Arterioscler Thromb Vasc Biol. 2019 Jul;39(7):1307-1316. doi: 10.1161/ATVBAHA.118.311576. Epub 2019 May 30.
2
CD73 (Cluster of Differentiation 73) and the Differences Between Mice and Humans.CD73(分化簇 73)与小鼠和人类的差异。
Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):339-348. doi: 10.1161/ATVBAHA.118.311579.
3
Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies-Statement From ATVB Council.
CD73:药物研发潜力及其在糖尿病和动脉粥样硬化中的应用
Front Immunol. 2024 Dec 12;15:1515875. doi: 10.3389/fimmu.2024.1515875. eCollection 2024.
4
CD73 deficiency does not aggravate angiotensin II-induced aortic inflammation in mice.CD73 缺乏不会加重血管紧张素 II 诱导的小鼠主动脉炎症。
Sci Rep. 2023 Oct 10;13(1):17125. doi: 10.1038/s41598-023-44361-7.
5
The Roles of Lipid Metabolism in the Pathogenesis of Chronic Diseases in the Elderly.脂质代谢在老年慢性病发病机制中的作用。
Nutrients. 2023 Aug 3;15(15):3433. doi: 10.3390/nu15153433.
6
The potential role and mechanism of circRNA/miRNA axis in cholesterol synthesis.环状 RNA/miRNA 轴在胆固醇合成中的潜在作用和机制。
Int J Biol Sci. 2023 May 29;19(9):2879-2896. doi: 10.7150/ijbs.84994. eCollection 2023.
7
Identifiability of enzyme kinetic parameters in substrate competition: a case study of CD39/NTPDase1.鉴定酶动力学参数在底物竞争中的可识别性:以 CD39/NTPDase1 为例。
Purinergic Signal. 2024 Jun;20(3):257-271. doi: 10.1007/s11302-023-09942-1. Epub 2023 May 11.
8
Circulating Ectonucleotidases Signal Impaired Myocardial Perfusion at Rest and Stress.循环细胞外核苷酸酶在静息和应激时提示心肌灌注受损。
J Am Heart Assoc. 2023 May 2;12(9):e027920. doi: 10.1161/JAHA.122.027920. Epub 2023 Apr 29.
9
Molecular Mechanisms of Vascular Health: Insights From Vascular Aging and Calcification.血管健康的分子机制:血管老化和钙化的启示。
Arterioscler Thromb Vasc Biol. 2023 Jan;43(1):15-29. doi: 10.1161/ATVBAHA.122.317332. Epub 2022 Nov 22.
10
Adenosine signaling: Optimal target for gastric cancer immunotherapy.腺苷信号:胃癌免疫治疗的最佳靶点。
Front Immunol. 2022 Sep 16;13:1027838. doi: 10.3389/fimmu.2022.1027838. eCollection 2022.
考虑在实验性动脉病理学研究的设计和报告中纳入性别差异——来自 ATVB 理事会的声明。
Arterioscler Thromb Vasc Biol. 2018 Feb;38(2):292-303. doi: 10.1161/ATVBAHA.117.309524. Epub 2018 Jan 4.
4
Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies: A Scientific Statement From the American Heart Association.《动物动脉粥样硬化研究的设计、实施及报告建议:美国心脏协会科学声明》
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):e131-e157. doi: 10.1161/ATV.0000000000000062. Epub 2017 Jul 20.
5
Complete deletion of is atheroprotective in apolipoprotein E-deficient mice.在载脂蛋白E缺乏的小鼠中,[具体物质]的完全缺失具有抗动脉粥样硬化保护作用。 (注:原文中“Complete deletion of ”缺少具体所指物质,这里用[具体物质]表示)
J Lipid Res. 2017 Jul;58(7):1292-1305. doi: 10.1194/jlr.M072132. Epub 2017 May 9.
6
Ischemic Cerebroprotection Conferred by Myeloid Lineage-Restricted or Global CD39 Transgene Expression.髓系谱系限制或全身性CD39转基因表达赋予的缺血性脑保护作用。
Circulation. 2017 Jun 13;135(24):2389-2402. doi: 10.1161/CIRCULATIONAHA.116.023301. Epub 2017 Apr 4.
7
Ectonucleotidase CD39-driven control of postinfarction myocardial repair and rupture.CD39 外核苷酸酶驱动的心肌梗死后修复和破裂的控制。
JCI Insight. 2017 Jan 12;2(1):e89504. doi: 10.1172/jci.insight.89504.
8
Regulation of CD73 in the development of lower limb atherosclerosis.CD73在下肢动脉粥样硬化发生发展中的调控作用。
Purinergic Signal. 2017 Mar;13(1):127-134. doi: 10.1007/s11302-016-9545-0. Epub 2016 Nov 10.
9
Flow-dependent expression of ectonucleotide tri(di)phosphohydrolase-1 and suppression of atherosclerosis.外核苷酸三(二)磷酸水解酶-1的血流依赖性表达与动脉粥样硬化的抑制
J Clin Invest. 2015 Aug 3;125(8):3027-36. doi: 10.1172/JCI79514. Epub 2015 Jun 29.
10
Aberrant circulating levels of purinergic signaling markers are associated with several key aspects of peripheral atherosclerosis and thrombosis.异常循环的嘌呤能信号标志物与外周动脉粥样硬化和血栓形成的几个关键方面有关。
Circ Res. 2015 Mar 27;116(7):1206-15. doi: 10.1161/CIRCRESAHA.116.305715. Epub 2015 Feb 2.